Customized Pharmaceutics: Innovations for Diverse Populations
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 10 March 2025 | Viewed by 595
Special Issue Editors
Interests: nanotechnology; pharmaceutical technology, skin; cosmetics; pediatric products
Special Issues, Collections and Topics in MDPI journals
Interests: nanotechnology; pharmaceutical technology, skin; cosmetics; dermatological products; topical products
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The field of pharmaceutics continually evolves to meet the unique needs of diverse populations, including pediatrics, geriatrics, and veterinary medicine. The demand for customized pharmaceutical solutions tailored to specific requirements is continually rising. From developing age-appropriate formulations for children to addressing the complexities of medication management in the elderly, and catering to the distinct physiological characteristics of animals, the pursuit of innovation in customized pharmaceutics remains a challenge. Advances in the field comprise, for example, nanotechnology, 3D printing and taste-masking technologies for enhanced palatability. This Special Issue aims to explore the latest developments in this dynamic field, emphasizing the importance of addressing the diverse needs of pediatric, geriatric, and veterinary patients through innovative pharmaceutical approaches.
Dr. Irene Clemes Külkamp-Guerreiro
Dr. Renata Vidor Contri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- 3D printing
- quality by design
- patient-centric approaches
- customized pharmaceuticals
- pediatrics
- geriatrics
- veterinary medicine
- age-appropriate formulations
- taste masking
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
